Across TCGA pan-cancer cohorts, PUDPP3 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated PUDPP3 data layer.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher PUDPP3 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated PUDPP3 expression acts as an unfavorable survival marker.
KIRC and UCEC are the cancer types where PUDPP3 RNA most reproducibly stratifies survival.